<p>Hound Partners LLC 在最近向證券交易委員會（SEC）提交的 13F 表格中表示，在第二季度將其在 HCA Healthcare, Inc.（紐約證券交易所代碼：HCA - 免費報告）的持倉減少了 10.0%。該公司在季度內出售了 3,535 股後，持有 31,832 股 HCA Healthcare 的股票。HCA Healthcare 佔 Hound Partners LLC 投資組合的約 1.6%，是其第 17 大持倉。Hound Partners LLC 在 HCA Healthcare 的持股在最近的報告期末價值為 12,195,000 美元。</p>
<ul>
<li>MarketBeat 週報 – 07/28 - 08/01</li>
</ul>
<p>其他幾家對沖基金和機構投資者也對該公司的股份進行了增持或減持。挪威銀行在第二季度購買了 HCA Healthcare 的新股份，價值約為 1,152,408,000 美元。Price T Rowe Associates Inc. MD 在第一季度將其在 HCA Healthcare 的持股增加了 83.4%。Price T Rowe Associates Inc. MD 目前持有 2,399,372 股該公司的股票，價值 829,104,000 美元，此前在上個季度增持了 1,091,416 股。Viking Global Investors LP 在第二季度將其在 HCA Healthcare 的持倉增加了 58.5%。Viking Global Investors LP 目前持有 1,872,133 股該公司的股票，價值 717,214,000 美元，此前在上個季度購買了 690,773 股。Abdiel Capital Advisors LP 在第一季度購買了 HCA Healthcare 的新股份，價值約為 164,835,000 美元。最後，VIRGINIA RETIREMENT SYSTEMS ET Al 在第二季度購買了 HCA Healthcare 的新股份，價值約為 109,337,000 美元。目前，62.73% 的股票由機構投資者持有。</p>
<p>獲取 <strong>HCA Healthcare</strong> 警報：</p>
<h2>華爾街分析師預測增長</h2>
<p>幾位股票分析師對 HCA 股票發表了評論。瑞銀集團在 10 月 27 日的研究報告中將 HCA Healthcare 的目標價從 495.00 美元上調至 525.00 美元，並給予該公司 “買入” 評級。Zacks Research 在 11 月 27 日的報告中將 HCA Healthcare 的評級從 “強力買入” 下調至 “持有”。Oppenheimer 在 10 月 27 日的研究報告中將 HCA Healthcare 的目標價從 400.00 美元上調至 500.00 美元，並給予該公司 “跑贏大盤” 評級。Weiss Ratings 在週一的研究報告中重申了對 HCA Healthcare 的 “買入（b）” 評級。最後，高盛集團在 10 月 27 日的研究報告中將 HCA Healthcare 的目標價從 470.00 美元上調至 520.00 美元，並給予該股票 “買入” 評級。十四位研究分析師對該股票給予了買入評級，十位分析師給予了持有評級。根據 MarketBeat 的數據，該公司的共識評級為 “適度買入”，共識目標價為 475.95 美元。</p>
<ul>
<li>HCA Healthcare 能否振興市場最弱的行業？</li>
</ul>
<p><strong>查看我們關於 HCA Healthcare 的最新研究報告</strong></p>
<h2>內部買賣情況</h2>
<p>在其他消息中，執行副總裁 Michael R. Mcalevey 於 11 月 5 日星期三出售了 3,892 股該公司的股票。股票以平均價格 473.79 美元出售，總交易額為 1,843,990.68 美元。出售後，該執行副總裁持有 3,487 股該公司的股票，價值 1,652,105.73 美元。此交易代表其持倉減少了 52.74%。該出售在向證券交易委員會提交的文件中披露，文件可通過此鏈接獲取。公司內部人士持有該公司 1.30% 的股票。</p>
<h2>HCA Healthcare 股票表現</h2>
<ul>
<li>綜合醫療股票能否在公開市場上成功？</li>
</ul>
<p>HCA Healthcare 股票在週五開盤價為 484.67 美元。該股票的市值為 1,106 億美元，市盈率為 18.73，市盈增長比率為 1.42，貝塔值為 1.36。該股票的 50 日移動平均線為 465.59 美元，200 日移動平均線為 413.62 美元。HCA Healthcare, Inc. 的一年最低價為 289.98 美元，一年最高價為 520.00 美元。</p>
<p>HCA Healthcare（紐約證券交易所代碼：HCA - 獲取免費報告）最近於 10 月 24 日發佈了季度收益結果。該公司報告本季度每股收益為 6.96 美元，超出市場共識預期的 5.64 美元，超出幅度為 1.32 美元。HCA Healthcare 的淨利潤率為 8.53%，股本回報率為負 792.25%。該公司本季度的收入為 191.6 億美元，而市場共識預期為 185.5 億美元。在去年同期，該公司每股收益為 4.90 美元。HCA Healthcare 的季度收入同比增長 9.6%。HCA Healthcare 已設定 2025 財年的每股收益指導為 27.000-28.000。整體來看，賣方分析師預測 HCA Healthcare, Inc. 本財年將發佈 24.98 美元的每股收益。</p>
<h2>HCA Healthcare 分紅公告</h2>
<p>該公司最近還宣佈了一項季度分紅，將於 12 月 29 日星期一支付。12 月 15 日星期一的登記投資者將獲得每股 0.72 美元的分紅。這代表每年 2.88 美元的分紅，收益率為 0.6%。該分紅的除息日為 12 月 15 日星期一。HCA Healthcare 的分紅支付比率（DPR）為 11.13%。</p>
<h2>HCA Healthcare 公司簡介</h2>
<p>（免費報告）</p>
<p>HCA Healthcare, Inc. 通過其子公司在美國擁有和運營醫院及相關醫療實體。它經營提供醫療和外科服務的綜合醫院和急性護理醫院，包括住院護理、重症監護、心臟護理、診斷和急救服務；以及門診服務，如門診手術、實驗室、放射學、呼吸治療、心臟病學和物理治療。</p>
<h2>特色文章</h2>
<ul>
<li>我們更看好的五隻股票，勝過 HCA Healthcare</li>
<li>保護您的投資組合免受冠狀病毒影響的三隻股票</li>
<li>MarketBeat 週報 – 12/8 - 12/12</li>
<li>投資者必須瞭解的場外交易（OTC）股票</li>
<li>Synopsys 看到樂觀轉變，因 Ansys 整合推動增長</li>
<li>揭示 VWAP 的力量：交易者的關鍵指標</li>
<li>你能給自己最好的節日禮物是什麼？Costco 股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 $1,000 在 HCA Healthcare 嗎？</h2>
<p>在考慮 HCA Healthcare 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前... 而 HCA Healthcare 並不在名單上。</p>
<p>雖然 HCA Healthcare 目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

HCA控股

<p>Hound Partners LLC 在第二季度減少了對 HCA Healthcare 的持股比例，出售了 3,535 股，持股比例下降了 10%。HCA 現在佔 Hound 投資組合的 1.6%。機構投資者持有 HCA 股票的 62.73%。分析師對 HCA 的評級一致為 “適度買入”，目標價格為 475.95 美元。HCA 第三季度的收益超出預期，收入同比增長 9.6%。該股票開盤價為 484.67 美元，市值為 1,106 億美元</p>

<p>Hound Partners LLC reduced its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 10.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,832 shares of the company's stock after selling 3,535 shares during the quarter. HCA Healthcare makes up about 1.6% of Hound Partners LLC's investment portfolio, making the stock its 17th largest holding. Hound Partners LLC's holdings in HCA Healthcare were worth $12,195,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Hound Partners LLC 在最近向證券交易委員會（SEC）提交的 13F 表格中表示，在第二季度將其在 HCA Healthcare, Inc.（紐約證券交易所代碼：HCA - 免費報告）的持倉減少了 10.0%。該公司在季度內出售了 3,535 股後，持有 31,832 股 HCA Healthcare 的股票。HCA Healthcare 佔 Hound Partners LLC 投資組合的約 1.6%，是其第 17 大持倉。Hound Partners LLC 在 HCA Healthcare 的持股在最近的報告期末價值為 12,195,000 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 07/28 - 08/01</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週報 – 07/28 - 08/01</li>
</ul>
</div><p>Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Norges Bank bought a new stake in shares of HCA Healthcare during the second quarter valued at approximately $1,152,408,000. Price T Rowe Associates Inc. MD increased its holdings in HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock valued at $829,104,000 after acquiring an additional 1,091,416 shares during the last quarter. Viking Global Investors LP grew its position in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company's stock valued at $717,214,000 after purchasing an additional 690,773 shares in the last quarter. Abdiel Capital Advisors LP bought a new position in HCA Healthcare during the first quarter valued at approximately $164,835,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of HCA Healthcare during the 2nd quarter worth approximately $109,337,000. 62.73% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他幾家對沖基金和機構投資者也對該公司的股份進行了增持或減持。挪威銀行在第二季度購買了 HCA Healthcare 的新股份，價值約為 1,152,408,000 美元。Price T Rowe Associates Inc. MD 在第一季度將其在 HCA Healthcare 的持股增加了 83.4%。Price T Rowe Associates Inc. MD 目前持有 2,399,372 股該公司的股票，價值 829,104,000 美元，此前在上個季度增持了 1,091,416 股。Viking Global Investors LP 在第二季度將其在 HCA Healthcare 的持倉增加了 58.5%。Viking Global Investors LP 目前持有 1,872,133 股該公司的股票，價值 717,214,000 美元，此前在上個季度購買了 690,773 股。Abdiel Capital Advisors LP 在第一季度購買了 HCA Healthcare 的新股份，價值約為 164,835,000 美元。最後，VIRGINIA RETIREMENT SYSTEMS ET Al 在第二季度購買了 HCA Healthcare 的新股份，價值約為 109,337,000 美元。目前，62.73% 的股票由機構投資者持有。</p>
</div><p>Get <strong>HCA Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>HCA Healthcare</strong> 警報：</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><p>Several equities analysts have commented on HCA shares. UBS Group increased their price objective on shares of HCA Healthcare from $495.00 to $525.00 and gave the company a &#34;buy&#34; rating in a research report on Monday, October 27th. Zacks Research cut HCA Healthcare from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a report on Thursday, November 27th. Oppenheimer boosted their price objective on shares of HCA Healthcare from $400.00 to $500.00 and gave the company an &#34;outperform&#34; rating in a research report on Monday, October 27th. Weiss Ratings reiterated a &#34;buy (b)&#34; rating on shares of HCA Healthcare in a research report on Monday. Finally, The Goldman Sachs Group upped their target price on shares of HCA Healthcare from $470.00 to $520.00 and gave the stock a &#34;buy&#34; rating in a research note on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $475.95.</p>
<div class="lb-trans"><p>幾位股票分析師對 HCA 股票發表了評論。瑞銀集團在 10 月 27 日的研究報告中將 HCA Healthcare 的目標價從 495.00 美元上調至 525.00 美元，並給予該公司 “買入” 評級。Zacks Research 在 11 月 27 日的報告中將 HCA Healthcare 的評級從 “強力買入” 下調至 “持有”。Oppenheimer 在 10 月 27 日的研究報告中將 HCA Healthcare 的目標價從 400.00 美元上調至 500.00 美元，並給予該公司 “跑贏大盤” 評級。Weiss Ratings 在週一的研究報告中重申了對 HCA Healthcare 的 “買入（b）” 評級。最後，高盛集團在 10 月 27 日的研究報告中將 HCA Healthcare 的目標價從 470.00 美元上調至 520.00 美元，並給予該股票 “買入” 評級。十四位研究分析師對該股票給予了買入評級，十位分析師給予了持有評級。根據 MarketBeat 的數據，該公司的共識評級為 “適度買入”，共識目標價為 475.95 美元。</p>
</div><ul>
<li>Can HCA Healthcare Revive the Market’s Weakest Sector?</li>
</ul>
<div class="lb-trans"><ul>
<li>HCA Healthcare 能否振興市場最弱的行業？</li>
</ul>
</div><p><strong>View Our Latest Research Report on HCA Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 HCA Healthcare 的最新研究報告</strong></p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>內部買賣情況</h2>
</div><p>In other news, EVP Michael R. Mcalevey sold 3,892 shares of the firm's stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares of the company's stock, valued at $1,652,105.73. This trade represents a 52.74% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this link. Corporate insiders own 1.30% of the company's stock.</p>
<div class="lb-trans"><p>在其他消息中，執行副總裁 Michael R. Mcalevey 於 11 月 5 日星期三出售了 3,892 股該公司的股票。股票以平均價格 473.79 美元出售，總交易額為 1,843,990.68 美元。出售後，該執行副總裁持有 3,487 股該公司的股票，價值 1,652,105.73 美元。此交易代表其持倉減少了 52.74%。該出售在向證券交易委員會提交的文件中披露，文件可通過此鏈接獲取。公司內部人士持有該公司 1.30% 的股票。</p>
</div><h2>HCA Healthcare Stock Performance</h2>
<div class="lb-trans"><h2>HCA Healthcare 股票表現</h2>
</div><ul>
<li>Can Integrated Healthcare Stocks Succeed in Public Markets?</li>
</ul>
<div class="lb-trans"><ul>
<li>綜合醫療股票能否在公開市場上成功？</li>
</ul>
</div><p>HCA Healthcare stock opened at $484.67 on Friday. The stock has a market cap of $110.60 billion, a PE ratio of 18.73, a price-to-earnings-growth ratio of 1.42 and a beta of 1.36. The stock has a 50-day moving average of $465.59 and a two-hundred day moving average of $413.62. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $520.00.</p>
<div class="lb-trans"><p>HCA Healthcare 股票在週五開盤價為 484.67 美元。該股票的市值為 1,106 億美元，市盈率為 18.73，市盈增長比率為 1.42，貝塔值為 1.36。該股票的 50 日移動平均線為 465.59 美元，200 日移動平均線為 413.62 美元。HCA Healthcare, Inc. 的一年最低價為 289.98 美元，一年最高價為 520.00 美元。</p>
</div><p>HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter in the prior year, the company earned $4.90 EPS. HCA Healthcare's quarterly revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>HCA Healthcare（紐約證券交易所代碼：HCA - 獲取免費報告）最近於 10 月 24 日發佈了季度收益結果。該公司報告本季度每股收益為 6.96 美元，超出市場共識預期的 5.64 美元，超出幅度為 1.32 美元。HCA Healthcare 的淨利潤率為 8.53%，股本回報率為負 792.25%。該公司本季度的收入為 191.6 億美元，而市場共識預期為 185.5 億美元。在去年同期，該公司每股收益為 4.90 美元。HCA Healthcare 的季度收入同比增長 9.6%。HCA Healthcare 已設定 2025 財年的每股收益指導為 27.000-28.000。整體來看，賣方分析師預測 HCA Healthcare, Inc. 本財年將發佈 24.98 美元的每股收益。</p>
</div><h2>HCA Healthcare Dividend Announcement</h2>
<div class="lb-trans"><h2>HCA Healthcare 分紅公告</h2>
</div><p>The business also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare's dividend payout ratio (DPR) is 11.13%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了一項季度分紅，將於 12 月 29 日星期一支付。12 月 15 日星期一的登記投資者將獲得每股 0.72 美元的分紅。這代表每年 2.88 美元的分紅，收益率為 0.6%。該分紅的除息日為 12 月 15 日星期一。HCA Healthcare 的分紅支付比率（DPR）為 11.13%。</p>
</div><h2>HCA Healthcare Profile</h2>
<div class="lb-trans"><h2>HCA Healthcare 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.</p>
<div class="lb-trans"><p>HCA Healthcare, Inc. 通過其子公司在美國擁有和運營醫院及相關醫療實體。它經營提供醫療和外科服務的綜合醫院和急性護理醫院，包括住院護理、重症監護、心臟護理、診斷和急救服務；以及門診服務，如門診手術、實驗室、放射學、呼吸治療、心臟病學和物理治療。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than HCA Healthcare</li>
<li>3 Stocks to Protect Your Portfolio from the Coronavirus Contagion</li>
<li>MarketBeat Week in Review – 12/8 - 12/12</li>
<li>What Investors Must Know About Over-the-Counter (OTC) Stocks</li>
<li>Synopsys Sees Bullish Shift as Ansys Integration Drives Growth</li>
<li>Unveiling The Power Of VWAP: A Key Indicator For Traders</li>
<li>The Best Holiday Present You Can Give Yourself? Costco Stock</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，勝過 HCA Healthcare</li>
<li>保護您的投資組合免受冠狀病毒影響的三隻股票</li>
<li>MarketBeat 週報 – 12/8 - 12/12</li>
<li>投資者必須瞭解的場外交易（OTC）股票</li>
<li>Synopsys 看到樂觀轉變，因 Ansys 整合推動增長</li>
<li>揭示 VWAP 的力量：交易者的關鍵指標</li>
<li>你能給自己最好的節日禮物是什麼？Costco 股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=HCA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in HCA Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 $1,000 在 HCA Healthcare 嗎？</h2>
</div><p>Before you consider HCA Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 HCA Healthcare 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前... 而 HCA Healthcare 並不在名單上。</p>
</div><p>While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 HCA Healthcare 目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Hound Partners LLC 出售了 3,535 股 HCA 控股公司的股票 $HCA